You have 9 free searches left this month | for more free features.

S-649266

Showing 1 - 25 of 6,733

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Gram-Negative Bacterial Infections Trial (Cefiderocol, Standard of Care)

Not yet recruiting
  • Gram-Negative Bacterial Infections
  • (no location specified)
Oct 11, 2023

Gram-negative Bacterial Infections, Bloodstream Infections (BSI), Complicated Intra-abdominal Infection (cIAI) Trial in

Recruiting
  • Gram-negative Bacterial Infections
  • +6 more
  • Brussels, Belgium
  • +22 more
Jan 16, 2023

Urinary Tract Infections Trial (Cefiderocol, Imipenem/cilastatin)

Completed
  • Urinary Tract Infections
  • (no location specified)
Nov 20, 2019

Gram-negative Bacterial Infections, Hospital Acquired Bacterial Pneumonia (HABP), Complicated Urinary Tract Infection (cUTI)

Recruiting
  • Gram-negative Bacterial Infections
  • +3 more
  • Fort Worth, Texas
  • +21 more
Sep 23, 2022

Bacterial Pneumonia Trial in United States (Cefiderocol, Standard of Care Antibiotic)

Terminated
  • Bacterial Pneumonia
  • Aurora, Colorado
  • +6 more
Oct 14, 2020

Healthcare-associated Pneumonia (HCAP), Bloodstream Infections (BSI), Hospital Acquired Pneumonia (HAP) Trial in Worldwide

Completed
  • Healthcare-associated Pneumonia (HCAP)
  • +5 more
  • Hartford, Connecticut
  • +84 more
Dec 18, 2020

Bacterial Infections Trial (Cefiderocol)

Approved for marketing
  • Bacterial Infections
  • (no location specified)
Feb 25, 2020

Healthcare-associated Pneumonia (HCAP), Hospital Acquired Pneumonia (HAP), Ventilator Associated Pneumonia (VAP) Trial in

Completed
  • Healthcare-associated Pneumonia (HCAP)
  • +2 more
  • New Haven, Connecticut
  • +118 more
Oct 20, 2020

Schistosoma Related Bladder Diseases.

Not yet recruiting
  • Schistosoma Haematobium
  • Immunohistochemistry staining,
  • microscopic examination of urine
  • Assiut, Egypt
    Assiut University Hospital
Jul 4, 2023

Obesity, Healthy Volunteers Trial in Dallas (S309309, Itraconazole)

Recruiting
  • Obesity
  • Healthy Volunteers
  • Dallas, Texas
    Fortrea Clinical Research Unit Inc.
Oct 30, 2023

Myeloproliferative Disorders, Essential Thrombocythemia, Tumors Trial (JNJ-88549968)

Not yet recruiting
  • Myeloproliferative Disorders
  • +3 more
  • (no location specified)
Nov 21, 2023

Cancer Trial (Ipatasertib)

Not yet recruiting
  • Cancer
  • (no location specified)
May 16, 2023

Locally Advanced Gastric Adenocarcinoma, Chemo Effect Trial in Hanzhou (Docetaxel, Tegafur-Gimeracil-Oteracil)

Recruiting
  • Locally Advanced Gastric Adenocarcinoma
  • Chemotherapy Effect
  • Hanzhou, Zhejiang, China
    Gastrointestinal Department of Second Affiliated Hospital of Zhe
Apr 2, 2023

2WIN-S Portable Refractor Trial in Bangkok (2WIN-S portable refractor)

Active, not recruiting
  • 2WIN-S Portable Refractor
  • 2WIN-S portable refractor
  • Bangkok, Thailand
    Rajavithi Hospital
Nov 20, 2023

Multiple Myeloma Trial in Worldwide (Talquetamab, Teclistamab, Daratumumab)

Recruiting
  • Multiple Myeloma
  • Edmonton, Alberta, Canada
  • +12 more
Jan 27, 2023

Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell Trial in Worldwide (JNJ-75348780)

Recruiting
  • Lymphoma, Non-Hodgkin
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Birmingham, Alabama
  • +43 more
Jan 27, 2023

Acute Leukemias, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Worldwide (JNJ-75276617)

Recruiting
  • Acute Leukemias
  • +2 more
  • Duarte, California
  • +28 more
Jan 27, 2023

Diagnostic Value of Serum Cathepsin S and Chromogranin A in DKD

Not yet recruiting
  • Diabetic Kidney Disease
  • cathepsin S and chromogranin A
  • (no location specified)
Oct 5, 2023

Serplulimab,Gastric Cancer, Adjuvant Therapy Trial in Shanghai (Serplulimab, Docetaxel, S1)

Recruiting
  • Serplulimab,Gastric Cancer, Adjuvant Therapy
  • Shanghai, China
    Zhang Zizhen
Mar 3, 2023

Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell Trial in Worldwide (JNJ-64264681)

Recruiting
  • Lymphoma, Non-Hodgkin
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • New York, New York
  • +15 more
Jan 27, 2023

Relapsed or Refractory Multiple Myeloma Trial in Worldwide (JNJ-79635322)

Recruiting
  • Relapsed or Refractory Multiple Myeloma
  • Edegem, Belgium
  • +16 more
Jan 27, 2023

Multiple Sclerosis Trial in Knoxville (Tolebrutinib, Placebo)

Completed
  • Multiple Sclerosis
  • Knoxville, Tennessee
    New Orleans Clinical Research Site Number : 8400001
Oct 24, 2023

Non-carious Cervical Lesions Trial in Santiago (Evaporation time for 5 seconds, Evaporation time for 25 seconds,

Completed
  • Non-carious Cervical Lesions
  • Evaporation time for 5 seconds
  • +3 more
  • Santiago, Región Metropolitana, Chile
    Mario Felipe Gutiérrez Reyes
Jul 11, 2023

Postprandial Lipemia, Postprandial Glycemia, Gastric Emptying Trial in Kajang (HGI+palm olein, LGI+palm olein, HGI+soy bean oil)

Recruiting
  • Postprandial Lipemia
  • +2 more
  • HGI+palm olein
  • +3 more
  • Kajang, Selangor, Malaysia
    Malaysian Palm Oil Board
Jul 28, 2023

Pancreatic Ductal Adenocarcinoma, Advanced Solid Tumor Trial in Petaling Jaya (Dendritic cell + Cytokine-induced killer cell

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Advanced Solid Tumor
  • Dendritic cell + Cytokine-induced killer cell (DC+CIK) immunotherapy
  • Tegafur Only Product
  • Petaling Jaya, Kuala Lumpur, Malaysia
    Clinical Oncology Department, Ummc
Jul 12, 2023